XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock-based Compensation and Benefits | 3 Months Ended
--- | ---
Mar. 31, 2025
Stock-based Compensation and Benefits |
Stock-based Compensation and Benefits | Note 11 Stock-based Compensation and Benefits ​ The Company provides stock-based compensation in accordance with shareholder-approved plans. ​ To date, the Company has issued stock options, restricted stock and performance stock units under the plans. The Compensation Committee sets the option exercise price at the time of grant, but in no case is the exercise price less than the fair market value of a share of stock at the date of grant. ​ Stock options ​ At March 31, 2025, the Company had 560,386 stock options outstanding at a weighted average exercise price of $32.93. No stock options were granted during the three months ended March 31, 2025. Stock option expense is a component of salaries and benefits in the consolidated statements of operations and totaled $42.9 thousand and $0.1 million for the three months ended March 31, 2025 and 2024, respectively. At March 31, 2025, there was $0.1 million of total unrecognized compensation cost related to non-vested stock options granted under the plans. The cost is expected to be recognized over a weighted average period of 1.0 years. ​ Restricted stock awards ​ The Company issues primarily time-based restricted stock awards that vest over a range of a 1-3 year period. Restricted stock with time-based vesting was valued at the fair value of the shares on the date of grant as they are assumed to be held beyond the vesting period. ​ Performance stock units ​ The Company grants PSUs which represent initial target awards and do not reflect potential increases or decreases resulting from the final performance results, which are to be determined at the end of the three-year performance period (vesting date). The actual number of shares to be awarded at the end of the performance period will range from 0% - 150% of the initial target awards. For PSU components granted in 2024, one-third of the award is based on the Company’s cumulative earnings per share (EPS target), one-third is based on the Company’s relative ROTA, and one-third is based on the Company’s cumulative TSR during the performance period. On the vesting date, the Company’s annual ROTA will be compared to the respective ROTAs of companies comprising the S&P 600 Regional Banks group. The Company’s ranking will be averaged over the measurement period to determine the shares awarded. The fair value of the ROTA award was determined based on the closing stock price of the Company’s common stock on the grant date. On the vesting date, the Company’s TSR will be compared to the respective TSRs of the companies comprising the S&P 600 Regional Banks group at the grant date to determine the shares awarded. The fair value of the TSR target portion of the award was determined using a Monte Carlo Simulation at the grant date. The fair value of the EPS target portion of the award was determined based on the closing stock price of the Company’s common stock on the grant date. ​ The weighted-average grant date fair value per unit for the awards granted during the year ended December 31, 2024 of the EPS target portion, ROTA target portion and TSR target portion were $35.41, $35.41, and $34.91, respectively. The initial weighted-average performance price for the TSR target portion granted during 2024 was $36.72. During the three months ended March 31, 2025, the Company awarded an additional 3,723 units due to final performance results related to performance stock units granted in 2022. ​ The following table summarizes restricted stock and performance stock unit activity during the three months ended March 31, 2025: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | Weighted
​ | ​ | Restricted | ​ | average grant- | ​ | Performance | ​ | average grant-
​ | ​ | stock shares | ​ | date fair value | ​ | stock units | ​ | date fair value
Unvested at December 31, 2024 | ​ | 292,014 | ​ | $ | 34.43 | ​ | 198,264 | ​ | $ | 34.31
Granted | ​ | 3,817 | ​ | ​ | 41.89 | ​ | — | ​ | ​ | —
Adjustment due to performance | ​ | — | ​ | ​ | — | ​ | 3,723 | ​ | ​ | 55.54
Vested | ​ | — | ​ | ​ | — | ​ | (51,658) | ​ | ​ | 39.63
Forfeited | ​ | (8,132) | ​ | ​ | 34.74 | ​ | (2,374) | ​ | ​ | 33.59
Unvested at March 31, 2025 | ​ | 287,699 | ​ | $ | 34.52 | ​ | 147,955 | ​ | $ | 33.00
​ As of March 31, 2025, the total unrecognized compensation cost related to the non-vested restricted stock awards and performance stock units totaled $3.8 million and $2.7 million, respectively, and is expected to be recognized over a weighted average period of approximately 1.8 years and 1.7 years, respectively. Expense related to non-vested restricted stock awards totaled $1.1 million and $1.0 million during the three months ended March 31, 2025 and 2024, respectively. Expense related to non-vested performance stock units totaled $0.5 million during the three months ended March 31, 2025 and 2024. Expense related to non-vested restricted stock awards and units is a component of salaries and benefits expense in the Company’s consolidated statements of operations. ​ Employee stock purchase plan ​ The 2014 ESPP is intended to be a qualified plan within the meaning of Section 423 of the Internal Revenue Code of 1986 and allows eligible employees to purchase shares of common stock through payroll deductions up to a limit of $25,000 per calendar year and 2,000 shares per offering period. The price an employee pays for shares is 90.0% of the fair market value of Company common stock on the last day of the offering period. The offering periods are the six-month periods commencing on March 1 and September 1 of each year and ending on August 31 and February 28 (or February 29 in the case of a leap year) of each year. There are no vesting or other restrictions on the stock purchased by employees under the ESPP. Under the ESPP, the total number of shares of common stock reserved for issuance totaled 400,000 shares, of which 206,431 was available for issuance at March 31, 2025. ​ Under the ESPP, employees purchased 8,099 shares and 11,620 shares during the three months ended March 31, 2025 and 2024, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration